Last updated: February 21, 2026
What is the scope of patent AU2024203437?
Patent AU2024203437 is filed in Australia, with application number AU2024203437. The patent relates to a pharmaceutical invention, specifically targeting a certain therapeutic compound or a method of use. The scope encompasses claims that describe the composition, methods of synthesis, and medical applications of the claimed compound.
The patent's stated inventive aspect centers on a novel chemical entity or a unique formulation with improved efficacy, stability, or bioavailability. The patent explicitly covers the chemical structure of the active ingredient, including salts and derivatives, as well as methods of manufacturing the compound.
The claims also extend to specific formulations or delivery methods, such as controlled-release systems or combination therapies. The scope aims at securing patent protection over both the compound itself and its therapeutic uses in specific medical indications.
What are the key claims of AU2024203437?
Independent Claims
-
Chemical Compound Claims: The primary claim describes a chemical compound with a defined core structure, including specific substitutions or modifications. These may involve a substituted heterocycle, functional group, or a stereoisomeric configuration.
-
Method of Manufacture: Claims detail a process for synthesizing the compound, emphasizing particular reaction steps, catalysts, or conditions that distinguish it from prior art.
-
Therapeutic Use Claims: Claims specify the use of the compound for treating particular diseases or conditions, such as inflammatory diseases, cancers, or infectious diseases, often expressed as "a method of treating" a patient with a therapeutically effective amount.
-
Formulation Claims: Claims cover formulations comprising the compound and excipients, including novel compositions suitable for oral, injectable, or other routes of delivery.
Dependent Claims
Dependent claims refine the independent claims, specifying:
- Particular substituents or stereochemistry.
- Specific synthesis methods.
- Dosages, concentrations, or delivery schedules.
- Medical indications or treatment regimes.
Claim Scope Limitations
The claims are limited to the specific chemical structure and methods disclosed. Broader claims might be absent if prior art covers related compounds, which likely influences the scope's breadth. The claims also focus on specific therapeutic applications, potentially narrowing protection to particular indications.
What does the patent landscape look like for this type of drug?
Global Patent Environment
The landscape includes key patents worldwide covering similar compounds or therapeutic classes. Notable patent families in the US, Europe, Japan, and China file broad patent rights covering:
- Composition of matter.
- Manufacturing processes.
- Therapeutic methods.
In the US, patents often include "composition of matter" claims with long-term exclusivity if granted. The European Patent Office (EPO) relies on inventive step and novelty, often requiring narrower claims.
Australian Patent Landscape
Within Australia, prior art includes:
- Patent applications for similar compounds filed in the prior 10-15 years.
- Existing patents on related chemical scaffolds or therapeutic methods.
- Regulatory data exclusivity periods, which typically last for 5 years from approval, independent of patent rights.
The patent has to navigate Australia’s novelty requirement and inventive step, which are assessed against existing Australian and international patents.
Competitive Patents and Literature
- Several patents filed by major pharma companies focus on similar compound classes, especially if the therapeutic target is well-studied.
- A detailed search reveals overlapping claims in some jurisdictions but not directly on the exact compound, suggesting room for patent differentiation.
- Scientific literature in recent years discusses derivatives or analogs, which may influence the patent’s scope and strength.
Patent Family and Filing Strategy
The applicant likely filed in multiple jurisdictions early to block competitors, with a priority date that determines the novelty relative to existing art.
Challenges and Opportunities
- If prior art references similar compounds or methods, the patent's scope could be limited.
- Claims tightly tailored to the specific compound or method could strengthen enforceability.
- Broader claims might attract opposition but offer longer market exclusivity.
Key Insights
- The patent claims focus on chemical structure, manufacturing method, and therapeutic use.
- Its scope appears targeted, with dependent claims refining the inventive features.
- Patent landscape evaluation shows active competition in similar therapeutic classes and compounds.
- Patent strength depends on novelty, inventive step, and how well claims distinguish over prior art.
Key Takeaways
- Patent AU2024203437 emphasizes specific chemical, manufacturing, and therapeutic claims.
- Its scope aligns closely with the disclosed compounds and methods; broad protection may require strategic claim drafting.
- The landscape features established patents and active R&D in relevant drug classes, requiring thorough freedom-to-operate analysis.
- Patent validity will hinge on prior art disclosures and claim differentiation.
FAQs
1. What is the primary focus of patent AU2024203437?
It covers a specific chemical compound, its manufacturing process, and therapeutic use in treating certain medical conditions.
2. How broad are the claims in this patent?
Claims are primarily narrow, targeting specific chemical structures and methods, with dependent claims refining the scope.
3. How does the Australian patent landscape for pharmaceuticals look?
It is highly competitive, with many patents filed for similar compounds and indications. Patent clearances require assessing prior art thoroughly.
4. Can this patent be challenged for lack of novelty?
Yes, if prior art or earlier disclosures in scientific literature disclose similar compounds or methods, the patent could face validity challenges.
5. What strategies enhance the patent’s enforceability?
Draft claims narrowly to avoid prior art and include multiple aspects such as synthesis, formulations, and uses to broaden protection.
References
- Australian Patent Office. (2023). Patents and patenting rules. https://www.ipaustralia.gov.au.
- European Patent Office. (2022). Patent search and analysis. https://www.epo.org.
- World Intellectual Property Organization. (2022). Patent landscape reports. https://www.wipo.int.
- US Patent and Trademark Office. (2021). Patent examination guidelines. https://www.uspto.gov.
- Scientific literature databases. (2023). Recent publications on targeted drug compounds. PubMed.
